U.S. Communications Stock News

NasdaqGS:OSUR
NasdaqGS:OSURMedical Equipment

OraSure Technologies (OSUR) Loss Worsening In Q1 2026 Challenges Bullish Margin Narratives

OraSure Technologies (OSUR) opened 2026 with Q1 revenue of US$27.9 million and a basic EPS loss of US$0.32, alongside a trailing twelve month revenue base of US$113.0 million and a basic EPS loss of US$1.04. Over recent quarters the company has seen revenue move from US$29.9 million in Q1 2025 and US$37.4 million in Q4 2024 to the latest US$27.9 million print. Quarterly basic EPS losses shifted from US$0.21 and US$0.14 in those periods to US$0.32, so investors are likely to focus on how...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

Brighthouse Financial (BHF) Q1 Loss Of US$792m Tests Bullish Profitability Narratives

Brighthouse Financial (BHF) opened 2026 with Q1 revenue of US$1.5b and a basic EPS loss of US$13.72, alongside net income excluding extra items of a US$792m loss. On a trailing 12 month basis, revenue stood at US$6.1b with a basic EPS loss of US$2.92 and a US$167m net loss. Over recent quarters the company has seen revenue move from US$2.4b in Q1 2025 to US$1.9b in Q4 2025 and US$1.5b in Q1 2026. Basic EPS has ranged from a loss of US$5.05 in Q1 2025 to a profit of US$10.80 in Q4 2024 before...
NasdaqGS:ATNI
NasdaqGS:ATNITelecom

ATN International (ATNI) EPS Loss Persists And Tests Bullish Profit-Recovery Narrative

ATN International (ATNI) opened 2026 with Q1 revenue of US$182.2 million and a basic EPS loss of US$0.18, while trailing 12 month revenue stood at US$730.9 million against a net loss of US$14.9 million. Over recent quarters, revenue has moved in a tight band between US$179.3 million and US$184.2 million. During the same period, basic EPS has swung from a profit of US$0.18 in Q3 2025 to losses of US$0.56 in Q2 2025 and US$0.32 in Q4 2025. This sets up a quarter where investors are focused less...
NYSE:MTB
NYSE:MTBBanks

M&T Bank Weighs In Footprint Deals To Deepen Regional Strength

M&T Bank is actively assessing targeted acquisitions within its 13 state footprint to increase regional scale. The company is focusing on adding density in existing markets rather than pursuing a national expansion strategy. This comes as regulators appear more open to bank mergers, creating a more supportive backdrop for deals. M&T Bank (NYSE:MTB) is sharpening its focus on regional growth, with management exploring acquisitions that fit within its existing footprint instead of chasing...
NasdaqCM:NVEC
NasdaqCM:NVECSemiconductor

NVE (NVEC) Net Margin Near 58% Tests Bearish Profitability Narratives

FY 2026 earnings snapshot and how the stories stack up NVE (NVEC) has just wrapped up FY 2026 with fourth quarter revenue of US$7.7 million and basic EPS of US$1.02, set against trailing twelve month revenue of US$26.3 million and EPS of US$3.14 as the stock trades at US$88.59. Over recent quarters the company has seen revenue range from US$6.1 million to US$7.7 million and quarterly EPS move between US$0.68 and US$1.02. This gives investors a clearer read on how the topline and per share...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum Pharmaceuticals (MIRM) Posts Huge US$790 Million Loss Challenging Bullish Profitability Narrative

Mirum Pharmaceuticals (MIRM) just posted Q1 2026 results with revenue of US$159.9 million, a basic EPS loss of US$13.43 and net income loss excluding extra items of US$790.2 million. The company has reported quarterly revenue of US$99.4 million in Q4 2024, US$111.6 million in Q1 2025, US$127.8 million in Q2 2025, US$133.0 million in Q3 2025 and US$148.9 million in Q4 2025, while EPS over those periods ranged between a loss of US$0.50 and a profit of US$0.06. For investors, a key focus this...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Baron Fund Puts Spotlight On Roivant’s Brepocitinib And Valuation Gap

Baron Health Care Fund recently highlighted Roivant Sciences (NasdaqGS:ROIV) for positive Phase 2 results of brepocitinib in cutaneous sarcoidosis. The fund called brepocitinib's data a potential major catalyst and suggested the market may be underestimating the drug's franchise value. This public endorsement draws fresh attention to Roivant's pipeline beyond earlier discussions about its valuation or analyst coverage. Roivant Sciences focuses on developing and commercializing therapies...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Freshpet (FRPT) Valuation Check After First Quarter Profit Turnaround And Brand Campaign Launch

Why Freshpet’s latest earnings matter for investors Freshpet (FRPT) just posted first quarter results showing sales of US$297.64 million and net income of US$48.51 million, compared with a net loss a year earlier. This has drawn fresh attention to the stock. See our latest analysis for Freshpet. Freshpet’s latest results and brand campaign land against a weaker price backdrop, with a 30 day share price return of 11.37% and a 1 year total shareholder return decline of 31.9%, suggesting longer...
NYSE:CMG
NYSE:CMGHospitality

Is Chipotle Mexican Grill (CMG) Attractive After A 35% One-Year Share Price Slide?

Curious whether Chipotle Mexican Grill at around US$33.27 is a bargain or still priced for perfection? This breakdown will help you put the current stock price into context. Over the last week the stock posted a 2.1% decline, and over the past year it has returned a 35.3% decline, which may have some investors questioning whether sentiment has shifted or if there is a potential opening. Recent coverage has focused on Chipotle's position as a major US fast-casual restaurant chain and how its...
NYSE:MDU
NYSE:MDUGas Utilities

MDU Resources Group (MDU) Q1 Margin Stability Tests Bullish Earnings Growth Narrative

MDU Resources Group (MDU) opened 2026 with Q1 revenue of $606 million and basic EPS of $0.39, while trailing 12 month revenue stood at about $1.8 billion and EPS at $0.93. This sets a clear baseline for how the business is currently earning its way. The company has seen quarterly revenue shift from $674.8 million in Q1 2025 to $606 million in Q1 2026, with basic EPS moving from $0.40 to $0.39 over the same period. This gives investors a straightforward read on how recent trading compares with...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Can Geron’s (GERN) Narrowing Losses Reframe Expectations For Its Blood Cancer Earnings Potential?

Geron Corporation has already reported first-quarter 2026 results, with revenue rising to US$51.84 million from US$39.6 million and net loss narrowing to US$3.64 million from US$19.84 million a year earlier, while also outlining upcoming May investor conference presentations on its blood cancer programs. The sharp reduction in quarterly net loss and loss per share, achieved alongside higher revenue, highlights how Geron’s commercial ramp is affecting its income statement. We’ll now examine...
NYSE:LNC
NYSE:LNCInsurance

Lincoln National (LNC) Q1 Loss Tests Bullish Margin Improvement Narrative

Lincoln National (LNC) kicked off Q1 2026 with revenue of US$5.3 billion and a basic EPS loss of US$1.10, as net income excluding extra items came in at a loss of US$201 million against a growing trailing twelve month earnings base. Over the last year, the company has seen trailing twelve month revenue move from US$18.0 billion to US$18.9 billion, while trailing basic EPS shifted from US$6.06 to US$8.69 and net income excluding extra items moved from US$1.0 billion to US$1.6 billion. In this...
NasdaqGS:ECPG
NasdaqGS:ECPGConsumer Finance

Encore Capital Group (ECPG) Profitability Return Tests Bearish Narratives In Q1 2026

Encore Capital Group (ECPG) opened Q1 2026 with total revenue of US$475.4 million and basic EPS of US$3.97, while trailing 12 month EPS sat at US$13.05 on revenue of US$1.9 billion. This provides a clear snapshot of both the latest quarter and the broader run rate. Over the past five quarters, the company has seen revenue move from US$265.6 million in Q4 2024 to US$392.8 million in Q1 2025 and then to US$475.4 million in Q1 2026. Quarterly basic EPS shifted from a loss of US$9.42 in Q4 2024...
NasdaqCM:CELH
NasdaqCM:CELHBeverage

Celsius Holdings (CELH) Margin Compression To 3.9% Tests Bullish Growth Narratives

Celsius Holdings (CELH) has put up a busy start to 2026, reporting Q1 revenue of US$782.6 million and basic EPS of US$0.33, alongside trailing twelve month revenue of US$3.0 billion and EPS of US$0.44. Over recent quarters the company has seen revenue move from US$332.2 million in Q4 2024 to between roughly US$329.3 million and US$739.3 million through 2025, while EPS has ranged from a loss of US$0.27 per share in Q3 2025 to US$0.35 per share in Q2 2025. With trailing net profit margins at...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Pagaya Technologies (PGY) Profit Run Rate Challenges Earnings Quality Skepticism

Pagaya Technologies (PGY) opened Q1 2026 with revenue of US$317.9 million and basic EPS of US$0.30, setting a clear marker for how its earnings engine is running right now. The company reported revenue of US$289.9 million and EPS of US$0.10 in Q1 2025 and US$334.8 million and EPS of US$0.40 in Q4 2025. This gives a clear view of how the top and bottom line have tracked into the current quarter, while net income of US$24.7 million keeps the focus firmly on margins. See our full analysis for...
NYSE:AGL
NYSE:AGLHealthcare

Agilon Health (AGL) Swings To Q1 Profit Challenging Longstanding Loss-Making Narrative

agilon health (AGL) opened 2026 with Q1 revenue of US$1.4b and basic EPS of US$1.80, alongside net income from continuing operations of about US$10.9m and earnings from discontinued operations of US$19m. The company has seen quarterly revenue fluctuate around the US$1.4b to US$1.6b range since early 2024, while trailing 12 month EPS sits at a loss of US$22.53 on net income from continuing operations of US$373.5m. This puts the spotlight firmly on how sustainably these latest margins have been...
NasdaqGM:VNDA
NasdaqGM:VNDABiotechs

Vanda Pharmaceuticals (VNDA) Losses Deepen To US$239.5 Million LTM Reinforcing Bearish Narratives

Vanda Pharmaceuticals (VNDA) opened Q1 2026 with total revenue of US$51.7 million and a basic EPS loss of US$0.82, while the trailing twelve months show revenue of US$217.8 million and a basic EPS loss of US$4.05. Over recent quarters the company has seen revenue move in a tight band between US$50.0 million and US$57.2 million and quarterly basic EPS losses range from US$0.08 to US$2.39. The latest figures fit into a pattern of steady sales alongside widening losses at the bottom line. For...
OTCPK:FMCC
OTCPK:FMCCDiversified Financial

Is It Time To Reconsider Federal Home Loan Mortgage (OTCPK:FMCC) After Recent Share Price Swings

Wondering if Federal Home Loan Mortgage at around US$7.14 is a bargain or already pricing in the key positives? This article breaks down what the current price might be implying about the stock. The stock has returned 0.6% over the last week and 26.4% over the past month, while the year-to-date return is a 31.0% decline and the 1-year return sits at 31.7%. Over the past 3 years the share price move has been very large relative to the starting point, and the 5-year return of 243.3% means...
NYSE:WTRG
NYSE:WTRGWater Utilities

Essential Utilities (WTRG) Margin Compression Tests Bullish Earnings Growth Narrative

Essential Utilities (WTRG) opened 2026 with Q1 revenue of US$861.8 million and basic EPS of US$0.79, against a backdrop where trailing 12 month revenue stood at about US$2.6 billion and EPS was US$1.97, alongside a clear step down in earnings over the most recent year. The company has seen quarterly revenue move from US$783.6 million in Q1 2025 to US$861.8 million in Q1 2026, while basic EPS shifted from US$1.03 to US$0.79 over the same period, presenting a picture in which investors are...
NasdaqGM:PDYN
NasdaqGM:PDYNMachinery

Palladyne AI (PDYN) Valuation After Reaffirmed 2026 Guidance And First Quarter 2026 Results

Why Palladyne AI stock is back in focus Palladyne AI (PDYN) has drawn fresh attention after reaffirming its 2026 revenue outlook of US$24 million to US$27 million and reporting first quarter 2026 results, including sales of US$3.54 million and a net loss of US$12.61 million. See our latest analysis for Palladyne AI. The reaffirmed 2026 guidance and first quarter revenue update come after a mixed price pattern, with a 1-day share price return of 4.8% decline, a 90-day share price return of...
NYSE:RGR
NYSE:RGRLeisure

Ruger (RGR) Returns To Slim Q1 Profit Challenging Loss Making Community Narrative

Q1 2026 results set the stage Sturm Ruger (RGR) has opened 2026 with Q1 revenue of US$141.4 million and basic EPS of roughly US$0.01, against a backdrop where the trailing twelve months show a basic EPS loss of US$0.75 on revenue of US$551.7 million. The company has seen quarterly revenue range from US$126.8 million to US$151.1 million over the past year, while basic EPS has swung from a profit of US$0.63 in late 2024 to a quarterly loss of US$1.05 in 2025 and back to a small profit in Q1...
NYSE:RRX
NYSE:RRXElectrical

Regal Rexnord (RRX) Earnings Momentum Outpaces Flat Revenue And Tests Bullish Narratives

Regal Rexnord (RRX) opened Q1 2026 with total revenue of US$1.48 billion, basic EPS of US$0.97 and net income of US$64.3 million, setting the tone for how the business is starting the year. Over the past year, the company has seen revenue move from US$6.03 billion to US$6.00 billion on a trailing basis while trailing EPS has shifted from US$2.95 to US$4.32 and net income from US$196.2 million to US$286.5 million, giving investors a clearer read on how earnings are tracking against a...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Vericel (VCEL) Q1 Loss Revives Valuation Concerns Despite Profitable Trailing Year

Vericel (VCEL) opened Q1 2026 with total revenue of US$68.4 million and a basic EPS loss of US$0.12, setting a clear focal point for how the market reads its latest update. Over recent periods the company has seen revenue move from US$52.6 million in Q1 2025 to US$68.4 million in Q1 2026, while basic EPS shifted from a loss of US$0.23 to a smaller loss of US$0.12, giving investors a clean read on how top line scale and earnings per share are tracking into this new quarter. Against that...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Radware (RDWR) Earnings Growth Outpaces Modest Revenue Rise And Tests Premium Valuation Narrative

Radware (RDWR) opened Q1 2026 with revenue of US$79.8 million and basic EPS of US$0.14, while earnings from discontinued operations were a loss of US$2.6 million. The company reported quarterly revenue increasing from US$72.1 million and EPS of US$0.10 in Q1 2025 to a range of roughly US$74 million to US$80 million and EPS between US$0.10 and US$0.14 from Q2 to Q4 2025. Over the same period, trailing 12 month earnings grew by 70.5%, and net margin improved from 4.1% to 6.4%. That combination...